Erratum: APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa (Journal of Clinical Investigation (2008) 118, 8 (2887-2895) DOI: 10.1172/JCI33760);APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa

Journal of Clinical Investigation

Volumn 118, Issue 8, 2008, Pages 2887-2895

  Huard, Bertrand ^a,b,e   McKee, Thomas ^b   Bosshard, Carine ^a,b   Durual, Stéphane ^a,f   Matthes, Thomas ^a   Myit, Samir ^b   Donze, Olivier ^c   Frossard, Christophe ^a   Chizzolini, Carlo ^a   Favre, Christiane ^a   Zubler, Rudolf ^a   Guyot, Jean Philippe ^a   Schneider, Pascal ^d   Roosnek, Eddy ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c Apotech Corporation   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e University Medical Center   (Switzerland)

^f UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; IMMUNOGLOBULIN G; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; PROTEOHEPARAN SULFATE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; INTESTINE VILLUS; MOUSE; MUCOSA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; TONSIL; UPREGULATION;

EID: 48749100460     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI33760C1     Document Type: Erratum

References (55)

1. Barreto, V.M., Ramiro, A.R., and Nussenzweig, M.C. 2005. Activation-induced deaminase: controversies and open questions. Trends Immunol. 26:90-96.
2. Schwickert, T.A., et al. 2007. In vivo imaging of germinal centres reveals a dynamic open structure. Nature. 446:83-87.
3. Manz, R.A., Hauser, A.E., Hiepe, F., and Radbruch, A. 2005. Maintenance of serum antibody levels. Annu. Rev. Immunol. 23:367-386.
4. Cassese, G., et al. 2003. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171:1684-1690.
5. Kunkel, E.J., and Butcher, E.C. 2003. Plasma-cell homing. Nat. Rev. Immunol. 3:822-829.
6. Pabst, O., et al. 2004. Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. J. Exp. Med. 199:411-416.
7. Kalled, S.L., Ambrose, C., and Hsu, Y.M. 2005. The biochemistry and biology of BAFF, APRIL and their receptors. Curr. Dir. Autoimmun. 8:206-242.
8. Ingold, K., et al. 2005. Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 201:1375-1383.
9. O'Connor, B.P., et al. 2004. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199:91-98.
10. Day, E.S., et al. 2005. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry. 44:1919-1931.
11. Thompson, J.S., et al. 2001. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 293:2108-2111.
12. Hendriks, J., et al. 2005. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ. 12:637-648.
13. Schiemann, B., et al. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science. 293:2111-2114.
14. Varfolomeev, E., et al. 2004. APRIL-deficient mice have normal immune system development. Mol. Cell. Biol. 24:997-1006.
15. Castigli, E., et al. 2004. Impaired IgA class switching in APRIL-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 101:3903-3908.
16. He, B., et al. 2007. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity. 26:812-826.
17. Xu, W., et al. 2007. Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat. Immunol. 8:294-303.
18. Salzer, U., et al. 2005. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37:820-828.
19. Merville, P., et al. 1996. Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J. Exp. Med. 183:227-236.
20. Medina, F., Segundo, C., Campos-Caro, A., Gonzalez-Garcia, I., and Brieva, J.A. 2002. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood. 99:2154-2161.
21. Withers, D.R., et al. 2007. T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue. Blood. 109:4856-4864.
22. Schwaller, J., et al. 2007. Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. Blood. 109:331-338.
23. Mhawech-Fauceglia, P., et al. 2006. The source of APRIL up-regulation in human solid tumor lesions. J. Leukoc. Biol. 80:697-704.
24. Clark, M.A., Wilson, C., Sama, A., Wilson, J.A., and Hirst, B.H. 2000. Differential cytokeratin and glycoconjugate expression by the surface and crypt epithelia of human palatine tonsils. Histochem. Cell Biol. 114:311-321.
25. Perry, M., and Whyte, A. 1998. Immunology of the tonsils. Immunol. Today. 19:414-421.
26. Brandtzaeg, P., and Johansen, F.E. 2005. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol. Rev. 206:32-63.
27. Tedder, T.F., and Engel, P. 1994. CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol. Today. 15:450-454.
28. Krajewski, S., et al. 1995. Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am. J. Pathol. 146:1309-1319.
29. Schwaller, J., et al. 2007. Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's disease. Leukemia. 21:1324-1327.
30. Ebenfelt, A., and Ivarsson, M. 2001. Neutrophil migration in tonsils. J. Anat. 198:497-500.
31. Sachse, F., Ahlers, F., Stoll, W., and Rudack, C. 2005. Neutrophil chemokines in epithelial inflammatory processes of human tonsils. Clin. Exp. Immunol. 140:293-300.
32. Claeys, S., et al. 2003. Human beta-defensins and toll-like receptors in the upper airway. Allergy. 58:748-753.
33. Chabot, S., Wagner, J.S., Farrant, S., and Neutra, M.R. 2006. TLRs regulate the gatekeeping functions of the intestinal follicle-associated epithelium. J. Immunol. 176:4275-4283.
34. Kucharzik, T., and Williams, I.R. 2002. Neutrophil migration across the intestinal epithelial barrier - summary of in vitro data and description of a new transgenic mouse model with doxycycline-inducible interleukin-8 expression in intestinal epithelial cells. Pathobiology. 70:143-149.
35. Liu, Y.J., et al. 1995. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity. 2:239-248.
36. Conley, M.E., and Delacroix, D.L. 1987. Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense? Ann. Intern. Med. 106:892-899.
37. Nadal, D., Soh, N., Schlapfer, E., Bernstein, J.M., and Ogra, P.L. 1992. Distribution characteristics of immunoglobulin-secreting cells in adenoids. Relationship to age and disease. Int. J. Pediatr. Otorhinolaryngol. 24:121-130.
38. Fagarasan, S., Kinoshita, K., Muramatsu, M., Ikuta, K., and Honjo, T. 2001. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature. 413:639-643.
39. Brandtzaeg, P., and Prydz, H. 1984. Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature. 311:71-73.
40. Ogra, P.L., Faden, H., and Welliver, R.C. 2001. Vaccination strategies for mucosal immune responses. Clin. Microbiol. Rev. 14:430-445.
41. Litinskiy, M.B., et al. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3:822-829.
42. Castigli, E., et al. 2005. TACI and BAFF-R mediate isotype switching in B cells. J. Exp. Med. 201:35-39.
43. Sakurai, D., et al. 2007. TACI regulates IgA production by APRIL in collaboration with HSPG. Blood. 109:2961-2967.
44. Belnoue, E., et al. 2008. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early life bone marrow stromal cells. Blood. 111:2755-2764.
45. Ng, L.G., et al. 2004. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J. Immunol. 173:807-817.
46. Benson, M.J., et al. 2008. Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J. Immunol. 180:3655-3659.
47. Sugita, K., et al. 1993. An infant with both autoimmune neutropenia and idiopathic thrombocytopenia with IgG2/IgA deficiency. Int. J. Hematol. 57:27-30.
48. Karlstrom, R., Gustafson, R., and Palmblad, J. 2001. Chronic mild neutropenia in adults: relation to IgG3 deficiency and infection susceptibility. J. Intern. Med. 250:342-347.
49. Cham, B., Bonilla, M.A., and Winkelstein, J. 2002. Neutropenia associated with primary immunodeficiency syndromes. Semin. Hematol. 39:107-112.
50. Sze, D.M., Toellner, K.M., Garcia de Vinuesa, C., Taylor, D.R., and MacLennan, I.C. 2000. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J. Exp. Med. 192:813-821.
51. Manz, R.A., Thiel, A., and Radbruch, A. 1997. Life-time of plasma cells in the bone marrow. Nature. 388:133-134.
52. Moser, K., Tokoyoda, K., Radbruch, A., MacLennan, I., and Manz, R.A. 2006. Stromal niches, plasma cell differentiation and survival. Curr. Opin. Immunol. 18:265-270.
53. Viard-Leveugle, I., et al. 2003. Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions. J. Biol. Chem. 278:16183-16188.
54. Huard, B., et al. 2004. BAFF production by antigen-presenting cells provides T cell co-stimulation. Int. Immunol. 16:467-475.
55. Arlettaz, L., Degermann, S., De Rham, C., Roosnek, E., and Huard, B. 2004. Expression of inhibitory KIR is confined to CD8+ effector T cells and limits their proliferative capacity. Eur. J. Immunol. 34:3413-3422.